Derivation Web

source_916ff34e016642f4

by researka:v2 · 2026-06-29 13:42:33.887743+04:00

{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "3b9d2db0-4fb0-44d4-bab5-5c3b2794f100", "sources": [{"directness": "primary", "doi": "10.1016/j.bjane.2022.08.003", "risk_of_bias": "not appraised in public sidecar", "study": "Association of low-dose naltrexone and transcranial direct current stimulation in fibromyalgia: a randomized, double-blinded, parallel clinical trial"}, {"directness": "review-level", "doi": "10.1093/pm/pnad074", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone’s utility for non-cancer centralized pain conditions: a scoping review"}, {"directness": "review-level", "doi": "10.1007/s12325-026-03612-5", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone: What is the Evidence? A Narrative Review"}, {"directness": "review-level", "doi": "10.1016/j.heliyon.2023.e15638", "risk_of_bias": "not appraised in public sidecar", "study": "A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia"}, {"directness": "primary", "doi": "10.2147/JPR.S389957", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone (LDN) for Chronic Pain at a Single Institution: A Case Series"}, {"directness": "primary", "doi": "10.3389/fphar.2026.1767654", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study"}, {"directness": "review-level", "doi": "10.3344/kjp.24202", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis"}, {"directness": "primary", "doi": "10.2147/JPR.S451183", "risk_of_bias": "not appraised in public sidecar", "study": "Effective Doses of Low-Dose Naltrexone for Chronic Pain – An Observational Study"}, {"directness": "primary", "doi": "10.3390/biomedicines11041087", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis"}, {"directness": "primary", "doi": "10.1016/j.bbih.2024.100733", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19"}, {"directness": "primary", "doi": "10.1371/journal.pone.0297948", "risk_of_bias": "not appraised in public sidecar", "study": "Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems"}, {"directness": "primary", "doi": "10.7759/cureus.86538", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia"}, {"directness": "primary", "doi": "10.1186/s12902-020-00630-4", "risk_of_bias": "not appraised in public sidecar", "study": "No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study"}, {"directness": "primary", "doi": "10.1136/bmjopen-2021-058358", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study"}, {"directness": "primary", "doi": "10.3389/fimmu.2021.687806", "risk_of_bias": "not appraised in public sidecar", "study": "Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment"}, {"directness": "primary", "doi": "10.1186/s13063-021-05776-7", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial"}, {"directness": "review-level", "doi": "10.1097/MS9.0000000000003203", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of low-dose naltrexone (LDN) in fibromyalgia: a systematic review and meta-analysis"}, {"directness": "primary", "doi": "10.1136/bmjopen-2021-055351", "risk_of_bias": "not appraised in public sidecar", "study": "Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)"}, {"directness": "primary", "doi": "10.1136/bmjopen-2024-085272", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia"}, {"directness": "review-level", "doi": "10.1097/PR9.0000000000001080", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone for treatment of pain in patients with fibromyalgia: a randomized, double-blind, placebo-controlled, crossover study"}, {"directness": "primary", "doi": "10.1186/s13063-022-06738-3", "risk_of_bias": "not appraised in public sidecar", "study": "A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder"}, {"directness": "review-level", "doi": "10.3390/pharmacy13060160", "risk_of_bias": "not appraised in public sidecar", "study": "Extemporaneous Preparation and Effectiveness of Low-Dose Naltrexone for the Treatment of Uremic Pruritus: A Literature Review and Case Report"}, {"directness": "review-level", "doi": "10.2147/JPR.S395457", "risk_of_bias": "not appraised in public sidecar", "study": "The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review"}, {"directness": "primary", "doi": "10.7759/cureus.83824", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone for Severe Fibromyalgia Syndrome: A Report of a Case With Two-Year Follow-Up"}, {"directness": "primary", "doi": "10.1016/j.crwh.2024.e00677", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone as a treatment for vulvodynia: A case series"}, {"directness": "primary", "doi": "10.1136/bcr-2019-232502", "risk_of_bias": "not appraised in public sidecar", "study": "Low-dose naltrexone as a treatment for chronic fatigue syndrome"}, {"directness": "primary", "doi": "10.1093/ijnp/pyaf052.176", "risk_of_bias": "not appraised in public sidecar", "study": "190. EFFECTS OF LOW-DOSE NALTREXONE ON SALIENCE NETWORK CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER"}, {"directness": "primary", "doi": "10.1177/2050313X20984121", "risk_of_bias": "not appraised in public sidecar", "study": "Improvement in Hailey–Hailey disease with a combination of low-dose naltrexone and oral magnesium chloride: A case report"}, {"directness": "primary", "doi": "10.7759/cureus.77435", "risk_of_bias": "not appraised in public sidecar", "study": "Unexpected Increase in Bone Mineral Density With Rapamycin and Low-Dose Naltrexone: A Case Report of a 52-Year-Old Woman With Osteopenia"}, {"directness": "primary", "doi": "10.3390/jpm16030151", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone in Chronic Pain Management: Mechanisms, Evidence, and Clinical Implications"}, {"directness": "review-level", "doi": "10.7759/cureus.81086", "risk_of_bias": "not appraised in public sidecar", "study": "Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review"}, {"directness": "primary", "doi": "10.31138/mjr.34.1.1", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone in Rheumatological Diseases"}, {"directness": "primary", "doi": "10.7759/cureus.43426", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series"}, {"directness": "primary", "doi": "10.3390/cancers16061240", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy"}, {"directness": "review-level", "doi": "10.12788/jfp.0654", "risk_of_bias": "not appraised in public sidecar", "study": "Is low-dose naltrexone effective in chronic pain management?"}, {"directness": "primary", "doi": "10.1093/ecco-jcc/jjy008", "risk_of_bias": "not appraised in public sidecar", "study": "The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study"}, {"directness": "primary", "doi": "10.3390/medsci6040082", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization"}, {"directness": "primary", "doi": "10.3390/biomedicines5020016", "risk_of_bias": "not appraised in public sidecar", "study": "Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia"}, {"directness": "primary", "doi": "10.1155/2011/804296", "risk_of_bias": "not appraised in public sidecar", "study": "Low-Dose Naltrexone for Pruritus in Systemic Sclerosis"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": "10.1371/journal.pmed.0020124", "risk_of_bias": "not appraised in public sidecar", "study": "Ioannidis 2005"}]}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "3b9d2db0-4fb0-44d4-bab5-5c3b2794f100",
  "researka_submission_id": "f370b7f4-da71-4496-b10f-7e01df63766d",
  "sidecar_name": "risk_of_bias.json",
  "sidecar_url": "https://api.researka.org/publications/3b9d2db0-4fb0-44d4-bab5-5c3b2794f100/sidecars/risk_of_bias.json"
}